1. Home
  2. PHAR vs CAC Comparison

PHAR vs CAC Comparison

Compare PHAR & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • CAC
  • Stock Information
  • Founded
  • PHAR 1988
  • CAC 1875
  • Country
  • PHAR Netherlands
  • CAC United States
  • Employees
  • PHAR N/A
  • CAC N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • CAC Major Banks
  • Sector
  • PHAR Health Care
  • CAC Finance
  • Exchange
  • PHAR Nasdaq
  • CAC Nasdaq
  • Market Cap
  • PHAR 627.5M
  • CAC 616.5M
  • IPO Year
  • PHAR N/A
  • CAC 1997
  • Fundamental
  • Price
  • PHAR $9.98
  • CAC $44.05
  • Analyst Decision
  • PHAR Strong Buy
  • CAC Hold
  • Analyst Count
  • PHAR 3
  • CAC 3
  • Target Price
  • PHAR $27.00
  • CAC $46.67
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • CAC 79.2K
  • Earning Date
  • PHAR 03-13-2025
  • CAC 01-28-2025
  • Dividend Yield
  • PHAR N/A
  • CAC 3.82%
  • EPS Growth
  • PHAR N/A
  • CAC N/A
  • EPS
  • PHAR N/A
  • CAC 3.20
  • Revenue
  • PHAR $285,745,000.00
  • CAC $168,756,000.00
  • Revenue This Year
  • PHAR $20.08
  • CAC N/A
  • Revenue Next Year
  • PHAR $9.22
  • CAC $30.91
  • P/E Ratio
  • PHAR N/A
  • CAC $13.71
  • Revenue Growth
  • PHAR 30.64
  • CAC N/A
  • 52 Week Low
  • PHAR $6.65
  • CAC $28.62
  • 52 Week High
  • PHAR $13.20
  • CAC $50.07
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • CAC 53.88
  • Support Level
  • PHAR $9.37
  • CAC $43.30
  • Resistance Level
  • PHAR $10.15
  • CAC $44.78
  • Average True Range (ATR)
  • PHAR 0.50
  • CAC 1.10
  • MACD
  • PHAR -0.09
  • CAC 0.31
  • Stochastic Oscillator
  • PHAR 57.53
  • CAC 83.45

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: